Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma.

Zhuang L, Wu Y, Han J, Ling X, Wang L, Zhu C, Fu Y.

Biomed Res Int. 2014;2014:278956. doi: 10.1155/2014/278956. Epub 2014 May 14.

2.

A systems biology-based classifier for hepatocellular carcinoma diagnosis.

Zhang Y, Wang S, Li D, Zhnag J, Gu D, Zhu Y, He F.

PLoS One. 2011;6(7):e22426. doi: 10.1371/journal.pone.0022426. Epub 2011 Jul 28.

3.

Analysis of hepatocellular carcinoma and metastatic hepatic carcinoma via functional modules in a protein-protein interaction network.

Pan J, Cong Z, Zhong M, Sun Y.

J Cancer Res Ther. 2014 Nov;10 Suppl:C186-94. doi: 10.4103/0973-1482.145866.

4.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
5.

Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ, Peng ZH.

Mol Oncol. 2012 Aug;6(4):445-57. doi: 10.1016/j.molonc.2012.04.001. Epub 2012 Apr 17.

6.

Dynamic protein interaction modules in human hepatocellular carcinoma progression.

Yu H, Lin CC, Li YY, Zhao Z.

BMC Syst Biol. 2013;7 Suppl 5:S2. doi: 10.1186/1752-0509-7-S5-S2. Epub 2013 Dec 9.

7.
8.

Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.

Liu F, Li H, Chang H, Wang J, Lu J.

Tumori. 2015 Mar-Apr;101(2):206-14. doi: 10.5301/tj.5000241. Epub 2015 Mar 13.

PMID:
25768320
9.
10.

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ.

Clin Cancer Res. 2008 Apr 1;14(7):2056-64. doi: 10.1158/1078-0432.CCR-07-1473.

11.

Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.

Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.

J Surg Oncol. 2012 Mar 15;105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3.

PMID:
22052684
12.

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L.

Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.

PMID:
21763068
13.

Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD.

Oncologist. 2011;16(7):1028-39. doi: 10.1634/theoncologist.2010-0358. Epub 2011 Jun 10.

14.

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.

Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.

J Gastroenterol Hepatol. 2013 Mar;28(3):565-75. doi: 10.1111/j.1440-1746.2012.07271.x.

PMID:
22989374
15.

Gene expression profiling analysis of hepatocellular carcinoma.

Kong D, Chen H, Chen W, Liu S, Wang H, Wu T, Lu H, Kong Q, Huang X, Lu Z.

Eur J Med Res. 2013 Nov 14;18:44. doi: 10.1186/2047-783X-18-44. Retraction in: Eur J Med Res. 2015;20:31.

16.

Identifying cancer biomarkers by network-constrained support vector machines.

Chen L, Xuan J, Riggins RB, Clarke R, Wang Y.

BMC Syst Biol. 2011 Oct 12;5:161. doi: 10.1186/1752-0509-5-161.

17.

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Liao R, Wu H, Yi Y, Wang JX, Cai XY, He HW, Cheng YF, Zhou J, Fan J, Sun J, Qiu SJ.

J Exp Clin Cancer Res. 2013 Apr 19;32:22. doi: 10.1186/1756-9966-32-22.

18.

Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.

Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.

Int J Oncol. 2006 Feb;28(2):383-91.

PMID:
16391793
19.

Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.

Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Mar;31(3):1305-13. doi: 10.3892/or.2013.2939. Epub 2013 Dec 20.

PMID:
24366000
20.

Discover the molecular biomarker associated with cell death and extracellular matrix module in ovarian cancer.

Liu Q, Guo J, Cui J, Wang J, Yi P.

Biomed Res Int. 2015;2015:735689. doi: 10.1155/2015/735689. Epub 2015 Mar 16.

Supplemental Content

Support Center